Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons

Current Opinion in HIV and AIDS

Volumn 11, Issue 5, 2016, Pages 514-520

  Petoumenos, Kathy ^a   Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

alcohol; drug use; HIV; life expectancy; smoking; survival

Indexed keywords

ACCIDENTAL DEATH; AGING; ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DANISH CITIZEN; DRUG ABUSE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; MORTALITY RISK; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SUDDEN DEATH; SUICIDE; SURVIVAL; ALCOHOLISM; CAUSE OF DEATH; DENMARK; DRUG DEPENDENCE; SURVIVAL ANALYSIS;

ALCOHOLISM; CAUSE OF DEATH; DENMARK; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; SMOKING; SUBSTANCE-RELATED DISORDERS; SURVIVAL ANALYSIS;

EID: 84975473693     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000306     Document Type: Review

References (61)

1. Rasmussen L, May M, Kronborg G, et al. Time trends in risk of severe agerelated diseases among persons with and without HIV infection; A Danish nationwide population-based cohort study. Lancet HIV 2015; 2:e288-e298.
2. Althoff KN, McGinnis KA, Wyatt CM, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDSdefining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 2015; 60:627-638.
3. Petoumenos K, Reiss P, Ryom L, et al. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV Med 2014; 15:595-603.
4. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict 2014; 23:582-590.
5. Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010; 100:1896-1903.
6. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010; 14:824-835.
7. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Decreased awareness of current smoking among healthcare providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007; 22:749-754.
8. Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS 2015; 29:221-229.
9. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56:727-734.
10. Rahmanian S, Wewers ME, Koletar S, et al. Cigarette smoking in the HIVinfected population. Proc Am Thorac Soc 2011; 8:313-319.
11. Clifford GM, Lise M, Franceschi S, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012; 106:447-452.
12. Hessol NA, Weber KM, D'Souza G, et al. Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. Am J Prev Med 2014; 47:53-69.
13. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24:1537-1548.
14. Helleberg M, Gerstoft J, Afzal S, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS 2014; 28:1499-1508.
15. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014; 384:241-248.
16. Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2013; 14:195-207.
17. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009; 21:40-53.
18. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006; 96:1060-1065.
19. Justice AC, McGinnis KA, Tate JP, et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend 2016; 161:95-103.
20. O'Connor JL, Gardner EM, Mannheimer SB, et al. Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. J Infect Dis 2013; 208:40-49.
21. Ompad DC, Kingdon M, Kupprat S, et al. Smoking and HIV-related health issues among older HIV-positive gay, bisexual, and other men who have sex with men. Behav Med 2014; 40:99-107.
22. Zyambo CM, Willig JH, Cropsey KL, et al. Factors associated with smoking status among HIV-positive patients in routine clinical care. J AIDS Clin Res 2015; 6; pii 480.
23. Aldaz P, Moreno-Iribas C, Egues N, et al. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health 2011; 11:300.
24. Murray M, Hogg RS, Lima VD, et al. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Med 2012; 13:89-97.
25. Gurm J, Samji H, Nophal A, et al. Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysis. CMAJ Open 2015; 3:E140-148.
26. Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev 2009; 21:106-121.
27. Mathers BM, Degenhardt L. Examining non-AIDS mortality among people who inject drugs. AIDS 2014; 28 (Suppl 4):S435-S444.
28. Grierson J, Pitts M, Koelmeyer R. HIV Futures Seven: The Health and Wellbeing of HIV Positive People in Australia, monograph series number 88.
29. Conen A, Wang Q, Glass TR, et al. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 64:472-478.
30. Daskalopoulou M, Rodger A, Phillips AN, et al. Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study. Lancet HIV 2014; 1:e22-e31.
31. Patterson S, Cescon A, Samji H, et al. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis 2015; 15:274.
32. Hull P, Mao L, Kolsee J, et al. Gay Community Periodic Survey: Sydney 2015.
33. Moore CL, Gidding HF, Jin F, et al. Patterns of drug use and drug-related hospital admissions in HIV-positive and-negative gay and bisexual men. AIDS Behav 2016. [Epub ahead of print]
34. Mathers BM, Degenhardt L, Bucello C, et al. Mortality among people who inject drugs: a systematic review and meta-Analysis. Bull World Health Organ 2013; 91:102-123.
35. Barrett SP, Darredeau C, Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol 2006; 21:255-263.
36. Marcus JL, Chao CR, Leyden WA, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr 2016. [Epub ahead of print]
37. McManus H, O'Connor CC, Boyd M, et al. Long-Term survival in HIV positive patients with up to 15 years of antiretroviral therapy. PLoS One 2012; 7:e48839.
38. Teeraananchai S, Kerr S, Amin J, et al. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: ameta-Analysis. HIVMedicine 2016.
39. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368:341-350.
40. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355.
41. Rosenthal E, Roussillon C, Salmon-Ceron D, et al. Liver-related deaths in HIVinfected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalite 2010 survey. HIV Med 2015; 16:230-239.
42. Kovari H, Sabin CA, Ledergerber B, et al. Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. Clin Infect Dis 2013; 56:870-879.
43. Morlat P, Roussillon C, Henard S, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS 2014; 28:1181-1191.
44. McManus H, Petoumenos K, Franic T, et al. Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PLoS One 2014; 9:e89089.
45. Worm SW, Bower M, Reiss P, et al. Non-AIDS defining cancers in the D:A:D Study-Time trends and predictors of survival: a cohort study. BMC Infect Dis 2013; 13:471.
46. Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early-And late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103:416-422.
47. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50:1387-1396.
48. Ingle SM, May MT, Gill MJ, et al. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIVinfected patients. Clin Infect Dis 2014; 59:287-297.
49. Calvo-Sanchez M, Perello R, Perez I, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med 2013; 14:40-48.
50. Rasmussen LD, Helleberg M, May MT, et al. Myocardial infarction among Danish HIV-infected individuals: population-Attributable fractions associated with smoking. Clin Infect Dis 2015; 60:1415-1423.
51. van der Helm J, Geskus R, Sabin C, et al. Effect of HCV infection on causespecific mortality after HIV seroconversion, before and after 1997. Gastroenterology 2013; 144:751-760.
52. Hernando V, Perez-Cachafeiro S, Lewden C, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol 2012; 57:743-751.
53. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-526.
54. Schwarcz SK, Vu A, Hsu LC, Hessol NA. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS Patient Care STDS 2014; 28:517-523.
55. Marin B, Thiebaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009; 23:1743-1753.
56. Jia CX, Mehlum L, Qin P. AIDS/HIV infection, comorbid psychiatric illness, and risk for subsequent suicide: a nationwide register linkage study. J Clin Psychiatry 2012; 73:1315-1321.
57. Petoumenos K, Worm S, Reiss P, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(-). HIV Med 2011; 12:412-421.
58. Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med 2015; 162:335-344.
59. Walsh N, Mijch A, Watson K, et al. HIV treatment outcomes among people who inject drugs in Victoria, Australia. BMC Infect Dis 2014; 14:707.
60. Humfleet GL, Delucchi K, Kelley K, et al. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev 2009; 21:54-64.
61. Shuter J, Salmo LN, Shuter AD, et al. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav 2012; 16:288-294.